title: [Multifactor immunopharmacological analysis. Effect of rifampicin and low-molecular immunomodulator of microbial origin on the primary immune response to fraction 1 of vaccine EV].
abstract: Multifactor analysis was applied to combined effect of a low molecular immunomodulator of microbial origin and rifampicin on the primary immune response (increased delayed type hypersensitivity and antibody titer) to the antigens of vaccine EV fraction I. Computer processing of the experimental data provided construction of the 2nd order polynomial models satisfactorily describing cellular and humoral responses in the combined therapy. For increasing the informative capacity of the analysis of the polynomial statistic models it was proposed to develop quasimonofactor relationships reflecting the factor effect on the output with changing of the other factors within the studied ranges. Nomograms (equal level lines at fixed values of one factor) were constructed which provided rapid and correct estimation of optimal values for the regulating parameters (drug doses and administration time). Immunostimulating activity of the microbial immunomodulator was estimated quantitatively and conditions for selective regulation of the cellular and humoral responses were determined.
authors.forename: A V
authors.initials: AV
authors.lastname: Nikitin
authors.forename: L P
authors.initials: LP
authors.lastname: Ivanitskaia
authors.forename: V M
authors.initials: VM
authors.lastname: Fishman
authors.forename: L E
authors.initials: LE
authors.lastname: Bodunkova
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D001426:Bacterial Proteins / Q000494:pharmacology*; D005163:Factor Analysis, Statistical; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D012293:Rifampin / Q000494:pharmacology*; D014612:Vaccines / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D001426:Bacterial Proteins; D014612:Vaccines; D012293:Rifampin
vernacular_title: Mnogofaktornyĭ immunofarmakologicheskiĭ analiz. Vliianie rifampitsina i nizkomolekuliarnogo immunomoduliatora mikrobnogo proiskhozhdeniia na pervichnyĭ immunnyĭ otvet k I fraktsii vaktsiny EV.